The individualized metabolic care program knows what your body needs and adapts with you over time
Abstract Background: Type 2 diabetes mellitus (T2D) is associated with an increased fracture risk
"When diagnoses rise shortly after starting a medication, that pattern often reflects finding something that was already there," said Rashmi Roy, MD, FACS, co-author of the white paper
HK-CHS Many living with T1D are unfortunately familiar with DKA
Effects of Glucagon-Like peptide 1 receptor agonists on atrial fibrillation recurrence after catheter ablation: A systematic review and Meta-analysis
Working with George Karavetsos, former director of FDAs Office of Criminal Investigations and a federal prosecutor, PSM analyzed the FDAs import records and related databases to investigate the origin, legality, and intended use behind the weight loss drug ingredients entering the U.S